Kenji Fukuda

Title: Kenji Fukuda: Innovator in Calcium-Sensing Receptor Antagonism

Introduction

Kenji Fukuda is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target calcium-sensing receptors. His work is essential for advancing therapeutic options for conditions such as osteoporosis.

Latest Patents

Fukuda holds a patent for a CaSR antagonist, which is a compound represented by a specific formula. This compound, along with its pharmaceutically acceptable salts and optically active forms, exhibits antagonistic action on calcium-sensing receptors. The patent also includes a pharmaceutical composition comprising this compound, particularly focusing on its application as a calcium receptor antagonist and a therapeutic drug for osteoporosis.

Career Highlights

Kenji Fukuda is associated with Japan Tobacco Inc., where he has been instrumental in research and development. His innovative approach has led to advancements in pharmaceutical formulations that can significantly impact patient care.

Collaborations

Fukuda has collaborated with notable colleagues, including Yuko Shinagawa and Teruhiko Inoue. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kenji Fukuda's contributions to the field of pharmaceuticals, particularly through his patent on calcium-sensing receptor antagonists, highlight his role as an innovator. His work continues to pave the way for new therapeutic options in treating osteoporosis.